Angel investor based in United States. 5 companies backed across 6 recorded rounds, Feb 2015 – Dec 2018.
Sectors of the companies in the portfolio, by company count.
Head-office city of the companies in the portfolio.
Rounds by stage.
Total size of the rounds they joined — an angel's own cheque is a share of this, and is not disclosed.
Every company Henri Termeer appears as an investor in, most recent round first.
| Company | City | Sectors | Latest round | Rounds | Round value |
|---|---|---|---|---|---|
| Aura Biosciences | Cambridge | GenomicsNanotechnologyOncology | Series C Dec 2018 | 1 | $42.3M |
| Arrakis Therapeutics | Waltham | OncologyCardiac and Vascular DisordersNeurology | Series A Feb 2017 | 1 | $38M |
| Lysosomal Therapeutics | Cambridge | NeurologyBiopharmaceuticalsNeurodegenerative Diseases Drugs | Series A Jan 2017 | 2 | $46.1M |
| Amylyx Pharmaceuticals | Cambridge | NeurologyBiopharmaceuticalsNeurodegenerative Diseases Drugs | Series A Aug 2016 | 1 | $5M |
| Artax Biopharma LED | Cambridge | ImmunologyBiopharmaceuticalsLife Sciences | Series B Sep 2015 | 1 | $10M |
Investors that appear in the same rounds. Two names in one round is what "invested together" means here — it is not a claim about a relationship off the cap table.
| Investor | Type | Based | Shared rounds | Shared companies |
|---|---|---|---|---|
| Advent Life Sciences | Firm | London | 3 | 3 |
| Bob Carpenter | Angel | 2 | 1 | |
| Hatteras Venture Partners | Firm | Durham | 2 | 1 |
| Lilly Ventures | Firm | Indianapolis | 2 | 1 |
| Atlas Venture | Firm | Cambridge | 2 | 1 |
| Sanofi Ventures | Firm | Paris | 2 | 1 |
| Roche | Firm | Basel | 2 | 1 |
| Pappas Capital | Firm | Durham | 1 | 1 |
| Pfizer | Firm | New York City | 1 | 1 |
| Partners Health Care Innovation | Firm | Cambridge | 1 | 1 |
| Lundbeck Foundation | Firm | Copenhagen | 1 | 1 |
| LI-COR | Firm | Lincoln | 1 | 1 |
| Celgene | Firm | Summit | 1 | 1 |
| ORHEP | Firm | Boston | 1 | 1 |
| Chiesi Ventures | Firm | Boston | 1 | 1 |
| Canaan | Firm | San Francisco | 1 | 1 |
| ALS Investment Fund | Firm | Amsterdam | 1 | 1 |
| Arix Bioscience | Firm | London | 1 | 1 |
| Morningside | Firm | Newton | 1 | 1 |
| Acks | Firm | 1 | 1 |